These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32005871)

  • 1. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
    Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
    HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
    Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
    Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
    [No Abstract]   [Full Text] [Related]  

  • 6. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
    Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
    Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
    Schullian P; Putzer D; Eberle G; Laimer G; Bale R
    J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe.
    Schullian P; Laimer G; Putzer D; Effenberger M; Bale R
    HPB (Oxford); 2020 Mar; 22(3):470-478. PubMed ID: 31591012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
    Bale R; Widmann G; Schullian P; Haidu M; Pall G; Klaus A; Weiss H; Biebl M; Margreiter R
    Eur Radiol; 2012 Apr; 22(4):930-7. PubMed ID: 22071776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.
    Haidu M; Dobrozemsky G; Schullian P; Widmann G; Klaus A; Weiss H; Margreiter R; Bale R
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1074-82. PubMed ID: 22006031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Amann A; Effenberger M; Maglione M; Freund MC; Loizides A; Bale R
    Eur Radiol; 2021 May; 31(5):3042-3052. PubMed ID: 33125554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
    Schullian P; Putzer D; Laimer G; Levy E; Bale R
    Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
    Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Westerlund P; Henninger B; Bale R
    Int J Hyperthermia; 2020; 37(1):564-572. PubMed ID: 32484004
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
    Widmann G; Schullian P; Haidu M; Bale R
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
    Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
    Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R
    PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians.
    Schullian P; Putzer D; Silva MA; Laimer G; Kolbitsch C; Bale R
    Front Oncol; 2019; 9():929. PubMed ID: 31608232
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
    Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
    Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas.
    Laimer G; Schullian P; Scharll Y; Putzer D; Eberle G; Oberhuber G; Bale R
    Int J Hyperthermia; 2022; 39(1):780-787. PubMed ID: 35654476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.